Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Readies Report On DTC, Says Physician Survey Supports Current Policy

Executive Summary

FDA expects to publish a report on its 1997 direct-to-consumer broadcast advertising policy this spring

You may also be interested in...



International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations

U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement

FDA To Release Three DTC Draft Guidances: Disease Awareness Is One Focus

FDA's upcoming draft guidances on direct-to-consumer advertising will encourage more use of disease awareness ads, Associate Commissioner for External Relations Peter Pitts said in a Jan. 23 speech to the advocacy group Families USA in Washington, D.C

DTC Advertising Research Needs FDA Funding, Marketing Coalition Says

FDA should establish a grants program to fund research on risk presentation in direct-to-consumer advertising, a coalition of marketing and media organizations says

Related Content

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel